Importer of Controlled Substances Registration, 13954 [2019-06845]
Download as PDF
<![CDATA[
13954
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
Importer of Controlled Substances
Registration
[Docket No. DEA–392]
ACTION:
Notice of registration.
ACTION:
SUMMARY:
The applicant listed below
has submitted an application for
registration to the Drug Enforcement
Administration (DEA) to become an
importer of a schedule I controlled
substance.
SUMMARY:
The
company listed below applied to be
registered as an importer of a basic class
of controlled substance. Information on
the previously published notice is listed
in the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for this notice.
SUPPLEMENTARY INFORMATION:
Company
FR docket
Almac Clinical Services Incorp (ACSI).
84 FR 3253
The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
Published
February 11, 2019.
Company
FR docket
Usona Institute .......................
83 FR 64365
ACTION:
Notice of registration.
The registrant listed below
has submitted an application for
registration to the Drug Enforcement
Administration (DEA) to become a bulk
manufacturer of various classes of
schedule I controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as a bulk manufacturer of
basic classes of schedule I controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
SUMMARY:
The applicant listed below
has submitted an application for
registration to the Drug Enforcement
Administration (DEA) to become an
importer of schedule I controlled
substances.
SUPPLEMENTARY INFORMATION:
jbell on DSK30RV082PROD with NOTICES
Notice of registration.
Bulk Manufacturer of Controlled
Substances Registration
Published
December
14, 2018.
Company
FR docket
Usona Institute ..........
83 FR 64364
Published
December 14, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this applicant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed applicant to import the applicable
basic class of schedule I controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security system, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer of
a schedule I controlled substance to the
above listed company.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed applicant to import the applicable
basic classes of schedule I controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I controlled substances to the
above listed company.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
Drug Enforcement Administration
[FR Doc. 2019–06845 Filed 4–5–19; 8:45 am]
[FR Doc. 2019–06847 Filed 4–5–19; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
Importer of Controlled Substances
Application: SpecGx LLC
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–06848 Filed 4–5–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
DATES:
VerDate Sep<11>2014
17:45 Apr 05, 2019
Jkt 247001
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Page 13954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06845]
[[Page 13954]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The applicant listed below has submitted an application for
registration to the Drug Enforcement Administration (DEA) to become an
importer of a schedule I controlled substance.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as an importer of a basic class of controlled substance.
Information on the previously published notice is listed in the table
below. No comments or objections were submitted and no requests for a
hearing were submitted for this notice.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
Almac Clinical Services Incorp 84 FR 3253...... February 11, 2019.
(ACSI).
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed applicant to
import the applicable basic class of schedule I controlled substance is
consistent with the public interest and with United States obligations
under international treaties, conventions, or protocols in effect on
May 1, 1971. The DEA investigated the company's maintenance of
effective controls against diversion by inspecting and testing the
company's physical security system, verifying the company's compliance
with state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer of a schedule I controlled substance to the above listed
company.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-06845 Filed 4-5-19; 8:45 am]
BILLING CODE 4410-09-P
